| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/28/2010 | US7803739 Substrates and assays for β-secretase |
| 09/28/2010 | US7803637 Compositions and methods for treatment of neoplastic disease |
| 09/28/2010 | US7803622 Adeno-associated virus vectors |
| 09/28/2010 | US7803615 Death domain containing receptor 5 |
| 09/28/2010 | US7803614 isolated host cell transfected with the recombinant expression vector encoding an immunogenic protein; diagnosis of skin cancer; vaccine for prevent and treatment; immunotherapy |
| 09/28/2010 | US7803613 Postweaning multisystemic wasting syndrome and porcine circovirus from pigs |
| 09/28/2010 | US7803603 Nematode ATP synthase subunit E polypeptide |
| 09/28/2010 | US7803602 Method for overexpression of zwitterionic polysaccharides |
| 09/28/2010 | US7803577 Polynucleotide encoding a tropoelastin polypeptide; expression products and hybrid molecules of the derivatives and variants |
| 09/28/2010 | US7803576 Nucleic acid sequences encoding VEGF-like factors and uses thereof |
| 09/28/2010 | US7803571 Using insulin receptor substrate peptides as diagnostic tool in identifying modulators of protein kinase activity; enzyme inhibitor; mimetics |
| 09/28/2010 | US7803566 Identifying T-cells in a sample that become activated in the presence of an amino acid sequence of a peptide with the same function as a CD8 T cell epitope of a vaccinia or variola virus; diagnosing vaccinia or variola virus infection by determining if the T-cells are activated by the peptide |
| 09/28/2010 | US7803564 EGF-like nucleic acids and polypeptides and uses thereof |
| 09/28/2010 | US7803562 Method for screening human intestinal Npt2B modulatory agents |
| 09/28/2010 | US7803560 Contacting a candidate antagonist with a MCP-1 receptor polypeptide having an amino acid sequence at least 95% homologous to an extracellular domain of a specific sequence, and comparing the binding of MCP-1 to the receptor polypeptide; decreased binding indicates an antagonist |
| 09/28/2010 | US7803552 Biomarkers for predicting prostate cancer progression |
| 09/28/2010 | US7803531 Anticancer, antitumor agents |
| 09/28/2010 | US7803524 Diagnostic compositions containing the polypeptide conjugated to a detectable label, such as radioisotopes, enzymes, fluorescent labels, antibody conjugates, or substrates |
| 09/28/2010 | US7803408 Use of human erythropoietin (EPO) to prevent or treat endothelial injury due to chemotherapy, radiation therapy, mechanical trauma, or to a disease state which damages the endothelium |
| 09/28/2010 | US7803393 Gas-plasma treatment of a substrate of medical implant; living cells coupled to a treated substrate may produce more of a growth factor than living cells coupled to an untreated substrate |
| 09/28/2010 | US7803388 Polymorphic membrane proteins or PMPs of Chlamydia, amino acid and nucleotide sequences; immunogens; vaccines; biodrugs;respiratory system disorders; urogenital system disorders; genetic engineering |
| 09/28/2010 | US7803387 With proteins of nisseria and purification of domains and gene expression of oligopeptides of ser, lys, ala, glu, gly and met |
| 09/28/2010 | US7803386 An immunogenic conjugate comprising a synthetic homopolymer of poly- gamma -glutamic acidpolypeptide covalently linked to a carrier, where the conjugate elicits an immune response against poly- gamma -glutamic acid ( gamma PGA) polypeptide; vaccine with fewer dosages; anthrax; diptheria |
| 09/28/2010 | US7803383 Method of treatment comprising administration of a cytokine antagonist molecule |
| 09/28/2010 | US7803379 Tumour-specific animal proteins |
| 09/28/2010 | US7803378 Antigen imitating extracellular areas of membrane proteins of type III produced from intracellular pathogenic micro-organisms, derived conformational antibodies and the use thereof |
| 09/28/2010 | US7803373 Chemokine panec-1 antibodies |
| 09/28/2010 | US7803362 Glycosylated with galactose-N-acetylgalactosamine; used for the introduction of exogenous nucleic acid sequences into the genome of avians in order to express the exogenous sequences to alter the phenotype of the avians or to produce desired proteins |
| 09/28/2010 | US7803361 Decreasing solid tumor size in a cancer patient by administering an interleukin-2 mutant with reduced vasopermeability activity compared to a wildtype form, and being Arg38Trp, wherein said wildtype form is human IL-2 mutant and the IL-2 mutant is not linked to an antibody. |
| 09/28/2010 | CA2422620C Method of controlling character of monocotyledon by modification and/or overexpression of cytochrome p450 monooxygenase gene involved in brassinosteroid biosynthesis and monocotyledon modified by the gene |
| 09/28/2010 | CA2371994C Enhancement of bactericidal activity of neisseria antigens with oligonucleotides containing cg motifs |
| 09/28/2010 | CA2323503C Novel physiological active peptide and its use |
| 09/28/2010 | CA2308201C Use of anti-fungal agents for the treatment of fungus-induced mucositis |
| 09/28/2010 | CA2285746C Osteoprotegerin binding proteins and receptors |
| 09/28/2010 | CA2208783C Methods for producing immunoglobulins containing protection proteins in plants and their use |
| 09/28/2010 | CA2188017C Cardiotrophin and uses therefor |
| 09/28/2010 | CA2153494C Novel parasitic helminth proteins |
| 09/27/2010 | CA2660622A1 Rig-i mutations and uses thereof in diagnostic and therapeutic virus-dependent immune applications |
| 09/23/2010 | WO2010108126A2 Reprogramming compositions and methods of using the same |
| 09/23/2010 | WO2010108005A2 Novel neural progenitors from pluripotent stem cells, methods of producing same and use to produce neural cells |
| 09/23/2010 | WO2010107778A1 Flagellin fusion proteins and use thereof to induce immune responses against pseudomonas aeruginosa |
| 09/23/2010 | WO2010107639A2 Isolation and characterization of novel green fluorescent proteins from copepods |
| 09/23/2010 | WO2010107560A2 Fungal cutinase from magnaporthe grisea |
| 09/23/2010 | WO2010107520A1 Soluble non-depot insulin conjugates and uses thereof |
| 09/23/2010 | WO2010107519A1 Terminally-functionalized conjugates and uses thereof |
| 09/23/2010 | WO2010107500A1 Vaccine compositions and methods for treatment of mucormycosis and other fungal diseases |
| 09/23/2010 | WO2010107405A1 Method for producing peptides which specifically recognize cells of particular types and can be used for therapeutic purposes |
| 09/23/2010 | WO2010107400A1 Genetically modified animal and method of obtaining the same |
| 09/23/2010 | WO2010107380A1 Immunomodulatory methods and systems for treatment and/or prevention of atherosclerosis and related proteins, peptides and compositions |
| 09/23/2010 | WO2010107068A1 METHOD FOR MEASURING β-GLUCAN, AND β-GLUCAN-BINDING PROTEIN FOR USE IN THE METHOD |
| 09/23/2010 | WO2010106770A1 Neil3 peptides and vaccines including the same |
| 09/23/2010 | WO2010106509A2 Hcv-derived polypeptides and uses thereof |
| 09/23/2010 | WO2010106441A2 Peptidomimetics for modulating interleukin-1 receptor |
| 09/23/2010 | WO2010106437A1 Peptides that inhibit angiotensin converting enzyme and peptides with antioxidant activity purified from ovotransferrin and methods of producing and using the same |
| 09/23/2010 | WO2010106294A1 Peptides modulating the activity of igf-1 and the applications of said peptides |
| 09/23/2010 | WO2010106293A1 Analogs of temporin-sha, and uses thereof |
| 09/23/2010 | WO2010105856A1 Methods and compositions for modulating cardiac contractility |
| 09/23/2010 | WO2010105817A2 Determination of interactions of constant parts of antibodies with fc-gamma receptors |
| 09/23/2010 | WO2010086512A3 Lactobacillus rhamnosus pilus polypeptides and methods for producing them |
| 09/23/2010 | WO2010086189A3 Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof |
| 09/23/2010 | WO2010085700A3 Treatment for obesity |
| 09/23/2010 | WO2010085295A3 Novel bacillus thuringiensis gene with lepidopteran activity |
| 09/23/2010 | WO2010076809A4 Glp-1 analogs and uses thereof |
| 09/23/2010 | WO2010060096A3 Compositions and methods for increasing cellulose production |
| 09/23/2010 | WO2010054362A3 Temperature-induced polynucleotides and uses therefor |
| 09/23/2010 | WO2010040147A3 Site-specific n-terminal modifications of proteins and conjugate formation |
| 09/23/2010 | WO2010020767A3 Glp-1 fusion polypeptides |
| 09/23/2010 | WO2009142773A4 Multivalent fibronectin based scaffold domain proteins |
| 09/23/2010 | US20100242137 Polynucleotides encoding proteins involved in plant metabolism |
| 09/23/2010 | US20100242134 Methods and polynucleotides for improving plants |
| 09/23/2010 | US20100242128 Method to produce modified plants with altered n-glycosylation pattern |
| 09/23/2010 | US20100240881 Therapeutic compositions |
| 09/23/2010 | US20100240876 Replikins and methods of identifying replikin-containing sequences |
| 09/23/2010 | US20100240874 Method for purifying cancer-specific proliferating cell nuclear antigen |
| 09/23/2010 | US20100240873 Ligand (act-4-l) to a receptor on the surface of activated cd4+ tcells |
| 09/23/2010 | US20100240871 Galactose Alpha(1-3) Galactose Compositions |
| 09/23/2010 | US20100240870 Composite organic-inorganic nanoclusters |
| 09/23/2010 | US20100240869 Gene related to growth promoting function of acetic acid bacterium, acetic acid bacterium bred using the gene and method for producing vinegar using the acetic acid bacterium |
| 09/23/2010 | US20100240868 Composition and Method for a Producing Stable Amyloid Beta Oligomers of High Molecular Weight |
| 09/23/2010 | US20100240866 Modified gherlin peptides |
| 09/23/2010 | US20100240865 Process for production of cyclic peptides |
| 09/23/2010 | US20100240774 Use of hydrophobin polypeptides as penetration enhancers |
| 09/23/2010 | US20100240742 Anti-angiogenic compositions and methods of use |
| 09/23/2010 | US20100240732 Aptamer-targeted sirna to prevent attenuation or suppression of a t cell function |
| 09/23/2010 | US20100240731 Lipopeptides for delivery of nucleic acids |
| 09/23/2010 | US20100240598 Peptides and peptide mimetics to inhibit the onset and/or progression of fibrotic and/or pre-fibrotic pathologies |
| 09/23/2010 | US20100240597 Methods of delivery of molecules to cells using a ricin subunit and compositions relating to same |
| 09/23/2010 | US20100240590 Peptides and related molecules that bind to tall-1 |
| 09/23/2010 | US20100240589 Diastereomeric peptides useful as inhibitors of membrane protein assembly |
| 09/23/2010 | US20100240586 Peg modified exendin or exendin analog and compositions and use thereof |
| 09/23/2010 | US20100240585 In vivo cell surface engineering |
| 09/23/2010 | US20100240584 Nematode-extracted serine protease inhibitors and anticoagulant proteins |
| 09/23/2010 | US20100240583 Soluble protein and utilization of the same |
| 09/23/2010 | US20100240582 Peptides and related molecules that modulate nerve growth factor activity |
| 09/23/2010 | US20100240577 Bacteriocins and Novel Bacterial Strains |
| 09/23/2010 | US20100240575 Anti-obese immunogenic hybrid polypeptides and anti-obese vaccine composition comprising the same |
| 09/23/2010 | US20100240146 Fluorescent protein particles |
| 09/23/2010 | US20100240145 Novel hemopoietin receptor protein, NR10 |
| 09/23/2010 | US20100240099 rBSA from K. lactis Expression, Secretion and Purification of Recombinant Bovine Serum Albumin (rBSA) from K. lactis and uses thereof |
| 09/23/2010 | US20100240096 Novel hemopoietin receptor protein, nr10 |